» Articles » PMID: 15314077

Multiple Distinct Sets of Stereotyped Antigen Receptors Indicate a Role for Antigen in Promoting Chronic Lymphocytic Leukemia

Abstract

Previous studies suggest that the diversity of the expressed variable (V) region repertoire of the immunoglobulin (Ig)H chain of B-CLL cells is restricted. Although limited examples of marked constraint in the primary structure of the H and L chain V regions exist, the possibility that this level of restriction is a general principle in this disease has not been accepted. This report describes five sets of patients, mostly with unmutated or minimally mutated IgV genes, with strikingly similar B cell antigen receptors (BCRs) arising from the use of common H and L chain V region gene segments that share CDR3 structural features such as length, amino acid composition, and unique amino acid residues at recombination junctions. Thus, a much more striking degree of structural restriction of the entire BCR and a much higher frequency of receptor sharing exists among patients than appreciated previously. The data imply that either a significant fraction of B-CLL cells was selected by a limited set of antigenic epitopes at some point in their development and/or that they derive from a distinct B cell subpopulation with limited Ig V region diversity. These shared, stereotyped Ig molecules may be valuable probes for antigen identification and important targets for cross-reactive idiotypic therapy.

Citing Articles

Autoimmunity promotes chronic lymphocytic leukemia progression in an indolent disease model.

Pfeuffer L, Siegert V, Trozzo R, Steiger K, Rad R, Ruland J Sci Rep. 2025; 15(1):4117.

PMID: 39900937 PMC: 11791097. DOI: 10.1038/s41598-025-86876-1.


Stereotyped B-Cell Receptor Immunoglobulins in B-Cell Lymphomas.

Agathangelidis A, Roussos A, Kardamiliotis K, Psomopoulos F, Stamatopoulos K Methods Mol Biol. 2024; 2865:125-143.

PMID: 39424723 DOI: 10.1007/978-1-0716-4188-0_6.


Expression Cloning of Antibodies from Single Human B Cells.

Rollenske T, Murugan R, Wardemann H, Busse C Methods Mol Biol. 2024; 2865:103-124.

PMID: 39424722 DOI: 10.1007/978-1-0716-4188-0_5.


Realizing precision medicine in chronic lymphocytic leukemia: Remaining challenges and potential opportunities.

Stamatopoulos K, Pavlova S, Al-Sawaf O, Chatzikonstantinou T, Karamanidou C, Gaidano G Hemasphere. 2024; 8(7):e113.

PMID: 39035106 PMC: 11260284. DOI: 10.1002/hem3.113.


An overview of prognostic markers in patients with CLL.

Braish J, Cerchione C, Ferrajoli A Front Oncol. 2024; 14():1371057.

PMID: 38817892 PMC: 11137234. DOI: 10.3389/fonc.2024.1371057.


References
1.
Potter M . Antigen-binding myeloma proteins of mice. Adv Immunol. 1977; 25:141-211. View

2.
Ghiotto F, Fais F, Valetto A, Albesiano E, Hashimoto S, Dono M . Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia. J Clin Invest. 2004; 113(7):1008-16. PMC: 379317. DOI: 10.1172/JCI19399. View

3.
Silverman G, Goldfien R, Chen P, Mageed R, Jefferis R, Goni F . Idiotypic and subgroup analysis of human monoclonal rheumatoid factors. Implications for structural and genetic basis of autoantibodies in humans. J Clin Invest. 1988; 82(2):469-75. PMC: 303536. DOI: 10.1172/JCI113620. View

4.
Sthoeger Z, Wakai M, Tse D, Vinciguerra V, Allen S, Budman D . Production of autoantibodies by CD5-expressing B lymphocytes from patients with chronic lymphocytic leukemia. J Exp Med. 1989; 169(1):255-68. PMC: 2189197. DOI: 10.1084/jem.169.1.255. View

5.
Kipps T, Tomhave E, Pratt L, Duffy S, Chen P, Carson D . Developmentally restricted immunoglobulin heavy chain variable region gene expressed at high frequency in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A. 1989; 86(15):5913-7. PMC: 297741. DOI: 10.1073/pnas.86.15.5913. View